U.S., ex rel. Polansky v. Executive Health Resources (599 U.S. 419)
U.S. Supreme Court · decided June 16, 2023 · Supreme Court Database (Spaeth)
- Citation
- 599 U.S. 419 · 143 S. Ct. 1720
- Decided
- June 16, 2023
- Term
- October Term 2022
- Vote
- 8–1
- Majority author
- Justice Kagan
- Issue area
- Economic Activity
- Disposition
- Affirmed
- Outcome
- Petitioning party lost
- Ideological direction
- Conservative
Opinion excerpt
PRELIMINARY PRINT Volume 599 U. S. Part 1 Pages 419–452 OFFICIAL REPORTS OF THE SUPREME COURT June 16, 2023 Page Proof Pending Publication REBECCA A. WOMELDORF reporter of decisions NOTICE: This preliminary print is subject to formal revision before the bound volume is published. Users are requested to notify the Reporter of Decisions, Supreme Court of the United States, Washington, D.C. 20543, pio@supremecourt.gov, of any typographical or other formal errors. OCTOBER TERM, 2022 419 Syllabus UNITED STATES ex rel. POLANSKY v. EXECUTIVE HEALTH RESOURCES, INC., et al. certiorari to the united states court of appeals for the third circuit No. 21–1052. Argued December 6, 2022—Decided June 16, 2023 The False Claims Act (FCA) imposes civil liability on any person who presents false or fraudulent claims for payment to the Federal Govern- ment. See 31 U. S. C. §§ 3729–3733. The statute is unusual in author- izing private parties (known as relators) to sue on the Government's behalf. Those suits—qui tam actions—are “brought in the name of the Government.” § 3730(b)(1). And the injury they assert is to the Gov- ernment alone. But in one sense, a qui tam suit is “for” the relator as well as the Government: If the action leads to a recovery, the relator may receive up to 30% of the total. §§ 3730(b)(1), (d)(1)–(2). Because a relator is no ordinary plaintiff, he is subject to special re-…
Excerpt of a 76,043-character opinion. The full text and citation network load in the interactive viewer above.